Dec 31, 2018

Neurocrine Biosciences Q4 2018 Earnings Report

Total Revenue
$131M
Previous year: $94.5M
+39.1%
EPS
$0.19
Previous year: $0.07
+171.4%
Gross Profit
$130M
Previous year: $93.8M
+38.6%
Cash and Equivalents
$142M
Previous year: $255M
-44.4%
Free Cash Flow
$44.4M
Previous year: $38.2M
+16.4%
Total Assets
$993M
Previous year: $818M
+21.5%

Neurocrine Biosciences

Neurocrine Biosciences